Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers.
暂无分享,去创建一个
Shaohua Zhang | Ling-mei Kong | Yan Li | J. Xia | Qihong Yang | Tao An | Wenxuan Zhang | Tong Qin | Jin Xiang | Song Wu | Hongna Wu | Minggao Xue | Dan Wang | Gang Xu | Guifeng Su | Kangfan Lei
[1] Xiaochun Li,et al. Mechanisms and inhibition of Porcupine-mediated Wnt acylation , 2022, Nature.
[2] R. Rahbarghazi,et al. The porcupine inhibitor WNT974 provokes ectodermal lineage differentiation of human embryonic stem cells , 2022, Cell biochemistry and function.
[3] Gang Yin,et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities , 2022, Signal Transduction and Targeted Therapy.
[4] D. Virshup,et al. Structural model of PORCN illuminates disease-associated variants and drug binding sites. , 2021, Journal of cell science.
[5] N. Ma,et al. Wnt pathway modulators in cancer therapeutics: An update on completed and ongoing clinical trials , 2021, International journal of cancer.
[6] Marie J Parsons,et al. WNT as a Driver and Dependency in Cancer. , 2021, Cancer discovery.
[7] Hao Peng,et al. Study on the potential active components and molecular mechanism of Xiao Huoluo Pills in the treatment of cartilage degeneration of knee osteoarthritis based on bioinformatics analysis and molecular docking technology , 2021, Journal of Orthopaedic Surgery and Research.
[8] Ya Zhang,et al. Targeting the Wnt/β-catenin signaling pathway in cancer , 2020, Journal of Hematology & Oncology.
[9] M. Maurice,et al. Mutations and mechanisms of WNT pathway tumour suppressors in cancer , 2020, Nature reviews. Cancer.
[10] S. Donnini,et al. How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance , 2020, Cancer drug resistance.
[11] N. Inestrosa,et al. Modulating Wnt signaling at the root: Porcupine and Wnt acylation. , 2019, Pharmacology & therapeutics.
[12] K. Carraway,et al. Wnt/PCP Signaling Contribution to Carcinoma Collective Cell Migration and Metastasis. , 2019, Cancer research.
[13] M. Najafi,et al. Cancer stem cells (CSCs) in cancer progression and therapy , 2018, Journal of cellular physiology.
[14] Bon-Kyoung Koo,et al. Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis , 2018, Cell.
[15] G. Reifenberger,et al. Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro , 2018, Oncotarget.
[16] Fan Yang,et al. Tumor‐suppressive miR‐145 co‐repressed by TCF4‐β‐catenin and PRC2 complexes forms double‐negative regulation loops with its negative regulators in colorectal cancer , 2018, International journal of cancer.
[17] Alissa C. Baker,et al. Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma , 2017, Oncotarget.
[18] R. Nusse,et al. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities , 2017, Cell.
[19] Hyunggee Kim,et al. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting , 2017, BMB reports.
[20] Youzhen Wang,et al. Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI. , 2017, Blood.
[21] J. Takahashi,et al. WNT‐C59, a Small‐Molecule WNT Inhibitor, Efficiently Induces Anterior Cortex That Includes Cortical Motor Neurons From Human Pluripotent Stem Cells , 2016, Stem cells translational medicine.
[22] N Harmston,et al. Wnt addiction of genetically defined cancers reversed by PORCN inhibition , 2015, Oncogene.
[23] Shi Hua Ang,et al. Discovery and Optimization of a Porcupine Inhibitor. , 2015, Journal of medicinal chemistry.
[24] H. Clevers,et al. Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia , 2015, Proceedings of the National Academy of Sciences.
[25] M. Lung,et al. Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment , 2015, Oncotarget.
[26] W. Sellers,et al. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974 , 2013, Proceedings of the National Academy of Sciences.
[27] M. Resh,et al. Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins. , 2013, Cell reports.
[28] Feng Cong,et al. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.
[29] Hai-Meng Zhou,et al. Inhibition of the Wnt palmitoyltransferase porcupine suppresses cell growth and downregulates the Wnt/β-catenin pathway in gastric cancer , 2013, Oncology letters.
[30] D. Bhartiya,et al. Very Small Embryonic-Like Stem Cells: Implications in Reproductive Biology , 2013, BioMed research international.
[31] R. Hannoush,et al. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. , 2013, Cancer research.
[32] X. Hao,et al. A reporter gene system for screening inhibitors of Wnt signaling pathway , 2013, Natural Products and Bioprospecting.
[33] L. Lum,et al. The Unusual Case of Porcupine , 2012, Science.
[34] Melanie A. Huntley,et al. Recurrent R-spondin fusions in colon cancer , 2012, Nature.
[35] H. Clevers,et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors , 2012, Nature.
[36] K. Garcia,et al. Structural Basis of Wnt Recognition by Frizzled , 2012, Science.
[37] H. Ruffner,et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner , 2012, Nature.
[38] Paul Polakis,et al. Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.
[39] Antara De,et al. Wnt/Ca2+ signaling pathway: a brief overview. , 2011, Acta biochimica et biophysica Sinica.
[40] R. Hannoush,et al. Membrane targeting of palmitoylated Wnt and Hedgehog revealed by chemical probes , 2011, FEBS letters.
[41] M. K. Harper,et al. WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification , 2010, Journal of Cell Science.
[42] R. Hannoush,et al. Imaging the lipidome: omega-alkynyl fatty acids for detection and cellular visualization of lipid-modified proteins. , 2009, ACS chemical biology.
[43] Christof Niehrs,et al. Wnt Induces LRP6 Signalosomes and Promotes Dishevelled-Dependent LRP6 Phosphorylation , 2007, Science.
[44] H. Koeppen,et al. The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. , 2007, Cancer research.
[45] L. Hawthorn,et al. Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells , 2007, Oncogene.
[46] N. Ueno,et al. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. , 2006, Developmental cell.
[47] S. Aaronson,et al. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. , 2004, Cancer cell.
[48] Hong Ma,et al. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[49] K. Hofmann. A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. , 2000, Trends in biochemical sciences.
[50] N. Perrimon,et al. The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. , 1996, Genes & development.
[51] H. Varmus,et al. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice , 1988, Cell.
[52] Harold E. Varmus,et al. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome , 1982, Cell.
[53] C. Nüsslein-Volhard,et al. Mutations affecting segment number and polarity in Drosophila , 1980, Nature.
[54] E. Ortiz-Sánchez,et al. ALDH as a Stem Cell marker in solid tumors. , 2018, Current stem cell research & therapy.